Company news
Rhythm Pharmaceuticals, Inc. news in 2019
Rhythm Pharmaceuticals, Inc.'s news releases, calls and decks from 2019, newest first.
Rhythm Pharmaceuticals Completes Enrollment of Pivotal Cohort in Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
December 4, 2019
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
November 3, 2019
Rhythm Pharmaceuticals Reports Third Quarter 2019 Financial Results
October 31, 2019
Rhythm Pharmaceuticals Announces Late-Breaking Data Presentations at ObesityWeek® 2019
October 29, 2019
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
October 17, 2019
Rhythm Pharmaceuticals Provides Update on Research and Development Programs
September 24, 2019
Decks in 2019
- Corporate Update (August 2019)
Corporate update · 24 slides · Aug 7, 2019
- Corporate Update (March 2019)
Corporate update · 17 slides · Mar 28, 2019
- Investor Presentation (January 2019)
Investor deck · 29 slides · Jan 8, 2019
- Technical Presentation (2019)
Technical · 17 slides · 2019
- Technical Presentation (2019)
Technical · 17 slides · 2019